Evidence map›Paper›PMID 41898479›Full record

ArticleInternational journal of molecular sciences2026

Proteome Analysis of Nasolacrimal Duct Lavage Fluid in Patients with Primary Acquired Nasolacrimal Duct Obstruction.

Heejeong You, Wonseok Bang, Byeongsoo Kang, Seunghoon Back, Junyoung Park, Minjung Ju, Jong-Moon Park, Helen Lew

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Heejeong YouDepartment of Ophthalmology, Bundang CHA Medical Center, CHA University, Seongnam-si 13496, Republic of Korea.
Wonseok BangBasil Biotech, Incheon 21984, Republic of Korea.ORCID 0009-0004-7718-0094
Byeongsoo KangBasil Biotech, Incheon 21984, Republic of Korea.
Seunghoon BackDepartment of Chemistry and Center for Proteogenome Research, Korea University, Seoul 02843, Republic of Korea.
Junyoung ParkBasil Biotech, Incheon 21984, Republic of Korea.
Minjung JuBasil Biotech, Incheon 21984, Republic of Korea.
Jong-Moon ParkBasil Biotech, Incheon 21984, Republic of Korea.ORCID 0000-0002-4407-1383
Helen LewDepartment of Ophthalmology, Bundang CHA Medical Center, CHA University, Seongnam-si 13496, Republic of Korea.ORCID 0000-0003-0121-3000

Funding

Ministry of SMEs and Startups (MSS, Korea) RS-2024-00487840National Research Foundation of Korea RS-2024-00469919
6 · The paper itself

Abstract

Primary acquired nasolacrimal duct obstruction (PANDO) is a common cause of epiphora in adults, yet the biochemical environment within the nasolacrimal duct (NLD) remains poorly understood. This study aimed to characterize the proteomic composition of NLD lavage fluid and identify subtype-specific molecular features distinguishing membranous and mucinous obstruction. Paired tear and NLD lavage fluid (NLD-LF) samples were collected from patients undergoing dacryoendoscopic recanalization, and proteomic profiling was performed using LC-MS/MS. A total of 1345 proteins were identified in NLD-LF and 767 in tear fluid, revealing a distinct NLD-specific proteome. Although the membranous and mucinous subtypes shared broadly similar protein compositions, differentially expressed proteins highlighted divergent biochemical pathways. The membranous subtype showed enrichment of keratinization-related processes involving

Indexed as

Lacrimal Duct ObstructionNasolacrimal DuctProteomeProteomicsAgedFemaleHumansMaleMiddle AgedTandem Mass SpectrometryTearsProteomeepiphoranasolacrimal duct irrigationPANDOtear proteomics

Identifiers

PMID41898479
PMCPMC13026466

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.